Company profile
Confo Therapeutics company profile
Confo Therapeutics is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need. Confo Therapeutics employs its proprietary CONFO technology to lock inherent unstable functional conformations of GPCRs as a superior starting point for drug discovery. CONFO body-stabilized active state conformations of these receptors disclose previously inaccessible structural features empowering the discovery of novel agonists for better therapeutic intervention.
Business identity
- Website
- http://confotherapeutics.com
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 51-100 employees
- Revenue range
- $1M-$10M
- Founded
- 2015-01-01, Year
Headquarters
- Headquarters
- Bullange, Wallonia, Belgium
- Postal code
- 1050
- Country code
- BE
- Continent
- Europe